Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

BRAF V600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules.

Wu Y, Xu T, Cao X, Zhao X, Deng H, Wang J, Li X, Yao Q, Ye X, Shen M, Wu X.

Cancer Biol Med. 2019 Feb;16(1):131-138. doi: 10.20892/j.issn.2095-3941.2018.0291.

2.

Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.

Zhang YZ, Xu T, Cui D, Li X, Yao Q, Gong HY, Liu XY, Chen HH, Jiang L, Ye XH, Zhang ZH, Shen MP, Duan Y, Yang T, Wu XH.

Sci Rep. 2015 Nov 24;5:16927. doi: 10.1038/srep16927.

3.

[Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].

Han Y, Zhao BW, Li SY, Lyu JG, Shou JD, Xu HS, Lou HY, Xu LL, Gao L, Xu SX, Zhu J.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Sep 7;52(9):686-691. doi: 10.3760/cma.j.issn.1673-0860.2017.09.010. Chinese.

PMID:
28910894
4.

Correlation between Ultrasound-based TIRADS and Bethesda System for Reporting Thyroid-cytopathology: 2-year Experience at a Tertiary Care Center in India.

Periakaruppan G, Seshadri KG, Vignesh Krishna GM, Mandava R, Sai VPM, Rajendiran S.

Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):651-655. doi: 10.4103/ijem.IJEM_27_18.

5.

Clinico-pathological Correlation of Thyroid Nodule Ultrasound and Cytology Using the TIRADS and Bethesda Classifications.

Singaporewalla RM, Hwee J, Lang TU, Desai V.

World J Surg. 2017 Jul;41(7):1807-1811. doi: 10.1007/s00268-017-3919-5.

PMID:
28251273
6.

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.

Paek SH, Kim BS, Kang KH, Kim HS.

World J Surg Oncol. 2017 Nov 13;15(1):202. doi: 10.1186/s12957-017-1266-5.

7.

Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective.

Naz S, Hashmi AA, Khurshid A, Faridi N, Edhi MM, Kamal A, Khan M.

Int Arch Med. 2014 Oct 31;7:46. doi: 10.1186/1755-7682-7-46. eCollection 2014.

8.
9.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
10.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
11.
12.

Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.

Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.

AJNR Am J Neuroradiol. 2018 Dec;39(12):2360-2365. doi: 10.3174/ajnr.A5898. Epub 2018 Nov 29.

PMID:
30498021
13.

Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.

Hong MJ, Na DG, Baek JH, Sung JY, Kim JH.

Thyroid. 2017 Jul;27(7):953-959. doi: 10.1089/thy.2016.0603. Epub 2017 May 19.

PMID:
28463597
14.

Ultrasound-guided Fine-needle Aspiration Cytology along with Clinical and Radiological Features in Predicting Thyroid Malignancy in Nodules ≥1 cm.

Chakravarthy NS, Chandramohan A, Prabhu AJ, Gowri M, Mannam P, Shyamkumar NK, Naik D, Cherian AJ, Thomas N, Paul MJ, Abraham D.

Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):597-604. doi: 10.4103/ijem.IJEM_1_18.

15.

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

PMID:
22500044
16.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.

PMID:
22181337
17.

Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.

Koh J, Choi JR, Han KH, Kim EK, Yoon JH, Moon HJ, Kwak JY.

PLoS One. 2013 May 24;8(5):e64505. doi: 10.1371/journal.pone.0064505. Print 2013.

18.

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation.

Zarif HA, Ghandurah SE, Al-Garni MA, Binmahfooz SK, Alsaywid BS, Satti MB.

Saudi J Med Med Sci. 2018 Sep-Dec;6(3):143-148. doi: 10.4103/sjmms.sjmms_178_17. Epub 2018 Aug 14.

19.

The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.

Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK.

Clin Endocrinol (Oxf). 2011 Dec;75(6):844-50. doi: 10.1111/j.1365-2265.2011.04154.x.

PMID:
21707687
20.

[Clinical role of BRAF V600E mutation testing in thyroid nodules].

Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jun;49(6):468-72. Chinese.

PMID:
25241863

Supplemental Content

Support Center